Hyrra Features the Latest and Most Talked-About Topstories News and Headlines from Around the World.
⎯ 《 Hyrra • Com 》

List of All Articles with Tag 'obesity'

Wegovy craze was all the rage on Q3 earnings calls
Wegovy craze was all the rage on Q3 earnings calls
By Bhanvi Satija and Savyata Mishra Weight loss was the talk of this earnings season, making names such
2023-11-20 14:25
Retail investors crowd into Eli Lilly after weight-loss drug approval
Retail investors crowd into Eli Lilly after weight-loss drug approval
By Bhanvi Satija and Amruta Khandekar Retail flows into Eli Lilly spiked to a more than two-year high
2023-11-17 21:23
Wegovy's heart benefits due to more than weight loss, Novo says
Wegovy's heart benefits due to more than weight loss, Novo says
By Patrick Wingrove PHILADELPHIA (Reuters) -Novo Nordisk on Saturday said the heart protective benefits of its wildly popular Wegovy obesity
2023-11-12 22:49
Eli Lilly: still seeking UK approval on pen for weight-loss drug
Eli Lilly: still seeking UK approval on pen for weight-loss drug
By Maggie Fick and Ludwig Burger LONDON Eli Lilly on Thursday said it has not yet gained approval
2023-11-09 21:46
Weight loss drugs transforming healthcare, may help with addiction -Reuters Events
Weight loss drugs transforming healthcare, may help with addiction -Reuters Events
By Julie Steenhuysen and Caroline Stauffer CHICAGO A new class of weight loss drugs is transforming the U.S.
2023-11-09 19:22
Factbox-Corporate America weighs risks of the Ozempic effect
Factbox-Corporate America weighs risks of the Ozempic effect
U.S. companies across sectors such as food and beverage makers and manufacturers of glucose monitors have faced investor
2023-10-20 10:53
Novo Nordisk's Wegovy bonanza looms large in Denmark
Novo Nordisk's Wegovy bonanza looms large in Denmark
By Maggie Fick COPENHAGEN The whirlwind success of weight-loss treatment Wegovy is providing a bonanza not just for
2023-10-05 14:53
U.S. FDA found lapses at Novo's main U.S. factory in May 2022 -report
U.S. FDA found lapses at Novo's main U.S. factory in May 2022 -report
By Maggie Fick LONDON (Reuters) -U.S. drug regulators issued a report detailing quality control lapses at Novo Nordisk's main factory
2023-09-21 16:57
Wegovy makes UK weight-loss debut even as Novo struggles with supplies
Wegovy makes UK weight-loss debut even as Novo struggles with supplies
By Maggie Fick LONDON Some Britons are set to be able to get Wegovy weight-loss injections after Novo
2023-09-04 23:49
Obesity drug data could boost companies' case for US coverage-analysts
Obesity drug data could boost companies' case for US coverage-analysts
By Patrick Wingrove New data on the heart benefit of an obesity drug from Novo Nordisk increases the
2023-08-10 13:26
Novo Nordisk weight-loss drug Wegovy launched in Germany, first big EU market
Novo Nordisk weight-loss drug Wegovy launched in Germany, first big EU market
By Ludwig Burger and Maggie Fick FRANKFURT Novo Nordisk has launched blockbuster weight-loss drug Wegovy in Germany, its
2023-07-29 22:48
Lilly's obesity drug leads to about 26% weight loss in new studies
Lilly's obesity drug leads to about 26% weight loss in new studies
By Bhanvi Satija and Leroy Leo (Reuters) -Eli Lilly said on Thursday its experimental obesity drug helped patients reduce 26.6%
2023-07-27 21:59
«12»